|
|
Office Locations:
|
22901 Millcreek Blvd., Suite 110
Cleveland, OH 44122
Phone: 216-378-9106
Fax: 216-378-9116
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Founded in 2002, NDI is a leading venture capital and commercialization firm that focuses on innovative neurodevice technologies to address significant unmet health conditions. NDI leverages its platform of innovative technologies to commercialize an extensive pipeline of neurotech opportunities, creating high-growth portfolio companies. In April 2008, NDI sold its first portfolio company to Medtronic Inc. for $42 million, returning over 150 times the original investment back to investors. NDI maintains a proprietary technology platform of neurodevices consisting of implantable pulse generators, external pulse generators, leads, surgical deployment tools, external programmers, and patient controllers that can be applied to many different therapeutic applications or adapted for new devices. Since 2008, the NDI Healthcare Fund and its portfolio companies have raised $26 million, including $17 million in private equity and another $9 million in grants and loans from sources such as the National Institutes of Health, U.S. Department of Defense, and the State of Ohio�€™s Third Frontier Program.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
